M
Medlogics Device Corporation
Medlogics has vertically integrated drug eluting coating, stent and catheter research, development and manufacturing at this facility
About Medlogics Device Corporation
Medlogics Device Corporation, established in 2002 and based in Santa Rosa, California, operates as a medical device company focused on the treatment of coronary artery disease. The company was founded by Jim Peacock, a serial entrepreneur who also founded other medical technology firms including Aclarion, Atrionix, and Nocimed. His repeated engagement in the medical device sector suggests a deep-rooted expertise and a persistent drive to address clinical challenges through new technologies.
The firm's core business involves the vertically integrated research, development, and manufacturing of drug-eluting stents and catheter solutions. This integrated model allows for in-house control over the entire production pipeline, from initial coating research to the final catheter and stent manufacturing. The company's stated mission was to provide safer and more effective implantable devices for patients and physicians globally. Medlogics concentrated its efforts on creating a next-generation drug-eluting stent, employing a distinct approach to both the stent's design and its drug delivery mechanism to improve outcomes for coronary artery disease.
Serving the medical technology market, the company's primary clients would be hospitals and physicians specializing in interventional cardiology. Its business model centered on the development and eventual sale of these specialized medical devices. One available source has described the company as deadpooled, indicating it may no longer be in operation. The company is also listed as part of the portfolio of EW Healthcare Partners, a healthcare investment firm.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VC✓Equity / VC | Nov 2008 | $30M | $120M | UBS | ↗ |
Growth signals
Latest recorded traffic for Medlogics Device Corporation is 30 monthly website visits, up 0% over the last three months. Medlogics Device Corporation's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Medlogics Device Corporation in the Santa Rosa ecosystem
The Medlogics Device Corporation office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later1 investor entered at this stage
UBS
Other known investors2 additional known investors
EW Healthcare Partners
Immanuel Thangaraj
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Medlogics Device Corporation on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Medlogics Device Corporation’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








